바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev
e-Submission

Vol.84 No.4
Citation Share

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2021, v.84 no.4, pp.338-339
https://doi.org/10.4046/trd.2021.0115
Putra Oki Nugraha (Hang Tuah University)
Hidayatullah Affan Y. N. (Hang Tuah University)
Putra, O. N. , & Hidayatullah, A. Y. N. (2021). Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline. Tuberculosis & Respiratory Diseases, 84(4), 338-339, https://doi.org/10.4046/trd.2021.0115
  • Downloaded
  • Viewed
PDF Download

Abstract

keywords

Reference

1.

1. Kang Y, Jo EJ, Eom JS, Kim MH, Lee K, Kim KU, et al. Treatment outcomes of patients with multidrug-resistant tuberculosis:comparison of pre- and post-public-private mix periods. Tuberc Respir Dis 2021;84:74-83.

2.

2. Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, et al. Culture conversion in patients treated with bedaquiline and/or delamanid: a prospective multicountry study. Am J Respir Crit Care Med 2021;203:111-9.

3.

3. Ministry of Health of Indonesia Republic. Programmatic management of drug resistance tuberculosis 2011-2014[Internet]. Jakarta: Ministry of Health of Indonesia Republic;2016 [cited 2021 Jul 20]. Available from: https://www.who. int/docs/default-source/searo/indonesia/non-who-publications/programmatic-management-of-drug-resistance-tb-inindonesia-2011-2014-bahasa.pdf?sfvrsn=aa2e3df1_2.

4.

4. Guglielmetti L, Jaspard M, Le Du D, Lachatre M, Marigot-Outtandy D, Bernard C, et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J 2017;49:1601799.

5.

5. Soeroto AY, Pratiwi C, Santoso P, Lestari BW. Factors affecting outcome of longer regimen multidrug-resistant tuberculosis treatment in West Java Indonesia: a retrospective cohort study. PLoS One 2021;16:e0246284.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy